ANIXA BIOSCIENCES INC (ANIX) Stock Fundamental Analysis

NASDAQ:ANIX • US03528H1095

2.76 USD
-0.08 (-2.82%)
Last: Feb 12, 2026, 11:09 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall ANIX gets a fundamental rating of 3 out of 10. We evaluated ANIX against 523 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for ANIX as it has an excellent financial health rating, but there are worries on the profitability. ANIX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year ANIX has reported negative net income.
  • ANIX had a negative operating cash flow in the past year.
  • In the past 5 years ANIX always reported negative net income.
  • In the past 5 years ANIX always reported negative operating cash flow.
ANIX Yearly Net Income VS EBIT VS OCF VS FCFANIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

  • The Return On Assets of ANIX (-67.95%) is worse than 61.76% of its industry peers.
  • The Return On Equity of ANIX (-72.07%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -67.95%
ROE -72.07%
ROIC N/A
ROA(3y)-54.85%
ROA(5y)-49%
ROE(3y)-58.39%
ROE(5y)-51.7%
ROIC(3y)N/A
ROIC(5y)N/A
ANIX Yearly ROA, ROE, ROICANIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400 -500

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ANIX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ANIX Yearly Profit, Operating, Gross MarginsANIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1K -2K -3K -4K -5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • The number of shares outstanding for ANIX has been increased compared to 1 year ago.
  • The number of shares outstanding for ANIX has been increased compared to 5 years ago.
  • ANIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ANIX Yearly Shares OutstandingANIX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ANIX Yearly Total Debt VS Total AssetsANIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • An Altman-Z score of 37.77 indicates that ANIX is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 37.77, ANIX belongs to the best of the industry, outperforming 94.46% of the companies in the same industry.
  • ANIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 37.77
ROIC/WACCN/A
WACCN/A
ANIX Yearly LT Debt VS Equity VS FCFANIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 8.08 indicates that ANIX has no problem at all paying its short term obligations.
  • The Current ratio of ANIX (8.08) is better than 74.76% of its industry peers.
  • A Quick Ratio of 8.08 indicates that ANIX has no problem at all paying its short term obligations.
  • The Quick ratio of ANIX (8.08) is better than 74.76% of its industry peers.
Industry RankSector Rank
Current Ratio 8.08
Quick Ratio 8.08
ANIX Yearly Current Assets VS Current LiabilitesANIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 10.26% over the past year.
EPS 1Y (TTM)10.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ANIX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.92% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0.91%
EPS Next 2Y0.46%
EPS Next 3Y-4.36%
EPS Next 5Y4.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ANIX Yearly Revenue VS EstimatesANIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2021 2023 2029 2030 2031 2032 2033 200M 400M 600M
ANIX Yearly EPS VS EstimatesANIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.5 -0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • ANIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ANIX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ANIX Price Earnings VS Forward Price EarningsANIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ANIX Per share dataANIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

  • ANIX's earnings are expected to decrease with -4.36% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.46%
EPS Next 3Y-4.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ANIX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ANIXA BIOSCIENCES INC

NASDAQ:ANIX (2/12/2026, 11:09:10 AM)

2.76

-0.08 (-2.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)01-12
Earnings (Next)03-09
Inst Owners14.88%
Inst Owner Change-3.67%
Ins Owners2.51%
Ins Owner Change3.04%
Market Cap90.86M
Revenue(TTM)N/A
Net Income(TTM)-10.93M
Analysts82
Price Target10.2 (269.57%)
Short Float %3.78%
Short Ratio3.36
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.45%
Min EPS beat(2)-0.84%
Max EPS beat(2)23.75%
EPS beat(4)3
Avg EPS beat(4)9.16%
Min EPS beat(4)-0.84%
Max EPS beat(4)23.75%
EPS beat(8)4
Avg EPS beat(8)3.95%
EPS beat(12)8
Avg EPS beat(12)11.47%
EPS beat(16)11
Avg EPS beat(16)10.9%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)11.11%
EPS NQ rev (1m)5%
EPS NQ rev (3m)0%
EPS NY rev (1m)1.45%
EPS NY rev (3m)-2%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.99
P/tB 5.99
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0
BVpS0.46
TBVpS0.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -67.95%
ROE -72.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-54.85%
ROA(5y)-49%
ROE(3y)-58.39%
ROE(5y)-51.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.08
Quick Ratio 8.08
Altman-Z 37.77
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y0.91%
EPS Next 2Y0.46%
EPS Next 3Y-4.36%
EPS Next 5Y4.92%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.21%
OCF growth 3YN/A
OCF growth 5YN/A

ANIXA BIOSCIENCES INC / ANIX FAQ

Can you provide the ChartMill fundamental rating for ANIXA BIOSCIENCES INC?

ChartMill assigns a fundamental rating of 3 / 10 to ANIX.


What is the valuation status of ANIXA BIOSCIENCES INC (ANIX) stock?

ChartMill assigns a valuation rating of 0 / 10 to ANIXA BIOSCIENCES INC (ANIX). This can be considered as Overvalued.


Can you provide the profitability details for ANIXA BIOSCIENCES INC?

ANIXA BIOSCIENCES INC (ANIX) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for ANIX stock?

The Earnings per Share (EPS) of ANIXA BIOSCIENCES INC (ANIX) is expected to grow by 0.91% in the next year.